Compare Eli Lilly And Co (LLY) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Vanguard Total International Stock Index Fund ETF — how do they compare? Eli Lilly And Co trades at $1,173.5 (market cap $1.02T), while Vanguard Total International Stock Index Fund ETF trades at $84.5. The key difference: Eli Lilly And Co pays a 0.6% dividend while Vanguard Total International Stock Index Fund ETF pays none. Which is the better fit depends on your goals.
| LLY | VXUS | |
|---|---|---|
Market Cap | $1.02T | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.24K | $87.06 |
52-Week Low | $625.65 | $68.24 |
Enterprise Value | $1.06T | — |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Vanguard Total International Stock Index Fund ETF
VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →
